DHR vs MU: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and Micron Technology, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-10.
Danaher Corporation Β· Healthcare
$195.98
+7.9% upside to fair value
Grade B High Quality
VS
Micron Technology, Inc. Β· Technology
$1,048.51
-45.0% upside to fair value
Grade C
QuantHub Verdict
DHR has more upside to fair value (+7.9%). MU trades at a lower forward P/E (23.4x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR MU
Current Price $195.98 $1,048.51
Fair Value Estimate $211.54 $576.68
Upside to Fair Value +7.9% -45.0%
Market Cap $138.7B $1,182.4B
Forward P/E 37.8x 23.4x
EV / EBITDA 22.8x 25.9x
Price / Sales 5.6x 13.1x
Price / FCF 26.2x 25.8x
Revenue Growth YoY +3.7% +345.7%
Gross Margin 60.7% 72.6%
Operating Margin 21.0% 65.7%
Return on Equity 7.1% 70.5%
Dividend Yield 0% 0%
FCF Yield 3.81% 3.87%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
MU β€” Micron Technology, Inc.
Micron Technology is a leading semiconductor company specializing in DRAM and NAND memory products, with a strong focus on high-value memory for cloud and AI applications. The company benefits from scale, advanced process technology, and U.S.-based manufacturing, but its competitive moat is narrow and cyclical compared to peers like Samsung and SK Hynix. Micron's recent financial performance is e…
Accumulation Zones
Metric DHR MU
Zone Low $158.66 $432.51
Zone High $179.81 $490.18
In Buy Zone? No No
← DHR Research    MU Research β†’    All Research